Research Article

Laser Acupuncture Alleviates Symptoms and Improves Quality of Life in Women with Overactive Bladder: A Double-Blind, Pilot Randomized Controlled Trial

Table 1

Baseline characteristics of participants.

CharacteristicsExperimental group (n = 15)Control group (n = 15)P value

Age, mean (SD)56.4 (14.3)60.9 (10.2)0.33a
Height (SD)156.9 (4.2)153 (6.2)0.06a
Weight (SD)59.5 (13.9)60.83 (17.9)0.90c
BMI (SD)24.1 (4.6)25.9 (7.3)0.49c
Diabetes mellitus (%)2 (13.3)3 (20)0.63b
HRT, n (%)1 (6.7)0 (0)0.31b
Education, n (%)0.30b
 Junior high school or below5 (33.3)5 (33.3)
 Senior high school6 (40.0)9 (60.0)
 College or above4 (26.7)1 (6.7)

Menopausal status, n (%)0.65b
 Pre5 (33.3)4 (26.7)
 Post10 (66.7)11 (73.3)

Parity, mean (SD, range)2.4 (1.4, 0–5)2.3 (1.4, 0–5)0.90a
Child delivery, n (%)1.0b
 Normal spontaneous delivery11 (73.3)11 (73.3)
 Cesarean section2 (13.3)2 (13.3)

Gynecology-related surgery (%)5 (33.3)8 (53.3)0.27b
Type of OAB (%)0.69b
 Wet OAB10 (66.7)11 (73.3)
 Dry OAB5 (33.3)4 (26.7)

Urodynamic test, mean (SD)
 Urethral pressure profile: bladder capacity (ml)292.3 (129.3)262.6 (101.4)0.51c
 CMG + EMG: Pves-Pabd (CmH2O)12.3 (28.5)10.4 (21.2)0.81c

Primary outcome, mean (SD)
 OABSS8.7 (1.8)8.5 (1.8)0.74c
  Q1 (daytime frequency)1.5 (0.5)1.7 (0.5)0.22c
  Q2 (nocturia)2.3 (0.9)2.4 (0.9)0.81c
  Q3 (urgency)3.9 (0.9)3.7 (1.1)0.78c
  Q4 (urgency incontinence)1.1 (1.4)0.7 (1.2)0.33c

Secondary outcome, mean (SD)
 UDI-66.0 (2.5)5.7 (2.4)0.62c
 IIQ-79.9 (5.7)10.8 (3.9)0.41c

aIndependent samples T test. bChi-square test, Pearson Chi-square, asymptotic significance (2-sided). cNonparametric test (Mann-Whitney U test). SD: standard deviation. BMI: body mass index. HRT: hormone replacement therapy. CMG: cystometry. EMG: external sphincter electromyogram. Pves: vesical pressure. Pabd: abdominal pressure. OABSS: overactive bladder symptom score. Q1: 1st question of OABSS, Q2: 2nd question of OABSS, Q3: 3rd question of OABSS, Q4: 4th question of OABSS. UDI-6: Urogenital Distress Inventory. IIQ-7: Incontinence Impact Questionnaire.